Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Asston Pharmaceuticals Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Asston Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Asston Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    31 Jul 2025, 2:46PM ANNOUNCEMENT UNDER REGULATION 30 OF LODR OF RECEIVING OF ORDER
  • Asston Pharma has submitted to BSE the Shareholding Pattern for the Period Ended July 17, 2025

    23 Jul 2025, 12:11PM As of July 2025, 50.66% is owned by Indian Promoters and 49.34% by Public. <p align=justify> Top three Promoters holding highest number of shares of A
  • Asston Pharma - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    23 Jul 2025, 11:57AM Disclosure in pursuance to regulation 30 and other applicable regulations of Listing obligation and Disclosure requirements, Regulation 2015 for recei
  • Asston Pharmaceuticals Ltd. debuts with 3.25% discount at Rs 119.00

    16 Jul 2025, 6:50PM Asston Pharmaceuticals Ltd. makes a weak debut on the bourses with scrip got listed at Rs 119.00 on the Bombay Stock Exchange, a 3.25 per cent discoun
  • Asston Pharma announces launch of initial public offering

    4 Jul 2025, 12:10PM Asston Pharmaceuticals Ltd. has announced public offering of 2241000 shares at a price of Rs 10.00 each for Cash at a Premium of Rs 113.00 per share.

Key fundamentals

Evaluate the intrinsic value of Asston Pharmaceuticals Ltd stock 

Name March-25 March-24
Assets 17.9749 13.2124
Liabilities 17.9749 13.2124
Equity 6.2714 0.7839
Gross Profit 6.1593 2.5458
Net Profit 4.3251 1.3603
Cash From Operating Activities -0.1628 -3.8003
NPM(%) 17.27 8.72
Revenue 25.0392 15.5862
Expenses 18.8799 13.0404
ROE(%) 33.37 10.49

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Asston Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 893.20 0.42 29.14 66.00 301.39 0.57
Lotus Eye Hospital and Institute Ltd 72.52 -1.89 207.11 240.51 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 22.09 -0.94 0.00 499.38 -39.50 0.00
Astec Lifesciences Ltd 890.00 -1.72 0.00 226.81 -601.21 0.00

Company Info

Our Company was originally incorporated as "Asston Pharmaceuticals Private Limited", a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from "Asston Pharmaceuticals Private Limited" to "Asston Pharmaceuticals Limited" vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. "Asston Pharmaceuticals Private Limited" under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company's achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.

Our Company was originally incorporated as "Asston Pharmaceuticals Private Limited", a private limited company under Companies Act, 2013, pursuant to a certificate of incorporation dated April 16, 2019 issued by Registrar of Companies, Mumbai, Maharashtra. Thereafter, our Company was converted into a public limited company and the name of our Company was changed from "Asston Pharmaceuticals Private Limited" to "Asston Pharmaceuticals Limited" vide fresh certificate of incorporation dated August 29, 2024 issued by the Registrar of Companies, Mumbai, Maharashtra. The Corporate Identification Number of our Company is U24304MH2019PLC324187.MAJOR EVENTS:2019- Incorporation of our Company viz. "Asston Pharmaceuticals Private Limited" under the guidance and leadership of Dr. Ashish Narayan Sakalkar and Mrs. Saili Jayaram More.- Our Company obtained Trade and Export Licenses for 3 major west African Countries namely Sierra Leone, Ghana and Liberia.2020- Our Company obtained registered trademarks in both India and abroad for multiple products,enhancing its images as a pharmaceutical brand in late 2020.2021- Our Company crossed the turnover of 10 cr turnover mark in 2021, less than two years since inception.2022- Established our Manufacturing unit in Mumbai which is one of our Company's achievement making us an independent and reliable supplier.2023- Our Company has successfully ventured into other African countries and is expected to receive registration from Asian markets like Cambodia and Vietnam.2024- Conversion of our Company from Private Limited to Public Limited Company.

Read More

Parent Organisation

Asston Pharmaceuticals Ltd.

Founded

16/04/2019

Managing Director

Dr.Ashish Narayan Sakalkar

NSE Symbol

FAQ

The current price of Asston Pharmaceuticals Ltd is

The 52-week high for Asston Pharmaceuticals Ltd is

The market capitalization of Asston Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Asston Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Asston Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Asston Pharmaceuticals Ltd shares.

The CEO of Asston Pharmaceuticals Ltd is Dr.Ashish Narayan Sakalkar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT